Skip to main content
VCbacked
Log inGet Started

Scilex Holding Company

Palo Alto, United States

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

$20.3M raised
Nov 2025
Post-IPO Equity
Health CareMedicalPharmaceutical

Top Investors

Frazier Healthcare PartnersYorkville AdvisorsPerigroveGraf Holdings

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Scilex Holding Company

How much funding has Scilex Holding Company raised?
Scilex Holding Company has raised $20.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Who are Scilex Holding Company's investors?
Scilex Holding Company's investors include Frazier Healthcare Partners, Yorkville Advisors, Perigrove, Graf Holdings.
Where is Scilex Holding Company headquartered?
Scilex Holding Company is headquartered in Palo Alto, United States.
What does Scilex Holding Company do?
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
What stage is Scilex Holding Company at?
Scilex Holding Company is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Scilex Holding Company — Funding & Investors." VCBacked, November 24, 2025, https://www.vcbacked.co/company/scilex-holding-company. Accessed July 3, 2026.
APA
VCBacked. (2025). Scilex Holding Company — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/scilex-holding-company
Wikipedia (cite web)
{{cite web |title=Scilex Holding Company — Funding & Investors |url=https://www.vcbacked.co/company/scilex-holding-company |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Oryl Photonics
Lausanne
Circl Brain Health Metrics
Victoria$354K
YLAH
Bern$589K